| |
Year:
2007
| Volume: 15
| Issue: 1-2
| Pages: 15-18
|
| |
Article |
| |
HER-2/neu OVEREXPRESSION IN INVASIVE DUCTAL BREAST CANCER – AN ASSOCIATION WITH OTHER PROGNOSTIC AND PREDICTIVE FACTORS
Ivkovic-Kapicl T, Kneževic-Ušaj S, Panjkovic M, Đilas-Ivanovic D, Golubovic M. |
| |
DOI:
10.2298/AOO0702015I |
| |
Abstract: |
| |
Background: HER-2/neu is a proto-oncogene that is amplified/overexpressed in 15 to 30% of invasive breast cancers. The purpose of this study was to determine if any relationship exist between HER-2/neu protein overexpression and estrogen receptor (ER), progesterone receptor (PR), grade, size, and lymph node status in female breast cancer.
Methods: A total of 100 cases of invasive ductal breast cancer were included in this study. The hormone receptors and HER-2/neu were studied immunohistochemically (IHC). Using the HER-2/neu DAKO scoring system, scores of 0, 1+ and 2+ were defined as negative and 3+ as positive.
Results: HER-2/neu protein overexpression was seen in 20 (20%) of cases. HER-2/neu protein overexpression was present in 4 of 52 T1 lesions (8%), in 11 of 37 T2 lesions (30%), in 3 of 6 T3 lesions (50%), and in 2 of 5 T4 lesions (40%), (p<0.05). Protein overexpression was seen in 7 of 17 grade III tumors (41%), and 13 of 61 grade II tumors (21%). Overexpression was not detected in grade I tumors (p<0.01). Of the 20 Her-2/neu positive cases, ER- and PR-negative status was detected in 60% and 70%, respectively.
Conclusion: Statistically significant correlation was found between HER-2/neu protein overexpression and large tumor size, high histological grade, and ER-, PR-negativity. There was no correlation with lymphonodal status. |
| |
Key words:
Breast Neoplasms; Carcinoma, Ductal, Breast; Receptor, erbB-2; Neoplasm Invasiveness; Immunohistochemistry; Proto-Oncogene Proteins; Gene Expression Regulation, Neoplastic |
| |
Read
full text in PDF [Full
Text] |
|
|